Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 40, 42-46, January 1, 1980]
© 1980 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kimler, B. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kimler, B. F.

Effect of Dihydroxyanthraquinone and Radiation on G2 Progression1

Bruce F. Kimler

Radiation Biology Laboratory, Department of Radiation Therapy, University of Kansas Medical Center, Kansas City, Kansas 66103

The effect of dihydroxyanthraquinone (DHAQ), a potential anticancer chemotherapeutic agent, on the progression of Chinese hamster ovary cells into mitosis and on the division delay induced by ionizing radiation was studied using the mitotic selection procedure for cell cycle analysis.

Following the addition of DHAQ, the number of mitotic cells selected from an asynchronous population remained unaltered for a refractory period and then decreased. This effect was concentration dependent with transition points between the S/G2 boundary at 10-4 µg/ml and the G2/M boundary at ≥102 µg/ml. The duration of the transient division delay was dependent upon the concentration of drug used and the duration of pulse exposure.

When cells were treated with pulses of DHAQ in addition to X-irradiation, there was no change in the location of the radiation transition point. There was an increase in the duration of division delay compared to that produced by X-ray alone that was dependent upon the concentration and duration of drug treatment.

The effect of DHAQ is similar to that of other cancer chemotherapeutic agents (Adriamycin, bleomycin, and lucanthone), and the same cautions should therefore be considered when combining DHAQ and radiation for clinical use.

1 Supported in part by Mid-America Cancer Center Program, National Cancer Institute Grant 5 P30 CA15080-04.

Received 4/30/79. Accepted 10/ 4/79.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1980 by the American Association for Cancer Research.